Last reviewed · How we verify
NCT05265494: USLEEP
Let´s Talk About Sleep in College Student
NA trial testing Non invasive neuromodulation NESA (XSIGNAL device) in Stress in 40 participants. Completed in 16 January 2023.
16 January 2023
Quick facts
| Lead sponsor | University of Las Palmas de Gran Canaria |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 15 November 2021 |
| Primary completion | 16 January 2023 |
| Estimated completion | 16 January 2023 |
| Sites | 2 locations across Spain |
Drugs / interventions tested
- Non invasive neuromodulation NESA (XSIGNAL device)
Conditions studied
- Stress — all drugs for Stress →
- Sleep Disturbance — all drugs for Sleep Disturbance →
Sponsor
University of Las Palmas de Gran Canaria
Who can join
Eligibility, any sex, with Stress or Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The concern about the quality of sleep of university students, future professionals of the world, must be crucial for the scientific community, as well as for university professors and professors. Innovative electrotherapy technologies such as non-invasive neuromodulation NESA are demonstrating effects on improving sleep quality, concentration and stress, so the objective of this project is to carry out a triple-blind randomized clinical trial with first-year science science students. health from three universities. The design is made up of an intervention group with NESA technology and another control group in each of the centers. Where the quality of sleep, perception of stress, cortisol levels in saliva and academic performance will be analyzed. This multicenter project hopes to demonstrate that non-invasive NESA neuromodulation can be a preventive treatment for the maintenance of sleep quality during stressful periods such as university exams, as well as being able to modulate perceived stress and translate into an improvement in student performance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05265494
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stress
Currently open trials in the same condition.
- NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
- NCT07469527 — Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults · NA · recruiting
- NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
- NCT07240792 — Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention for Rural High School Student · NA · recruiting
- NCT07518056 — Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students · recruiting
Other University of Las Palmas de Gran Canaria trials
Trials by the same sponsor.
- NCT04962737 — Non-invasive Neuromodulation NESA Through Somatosensory Evoked Potentials and Sympathetic-cutaneous Responses · NA · not yet recruiting
- NCT06417450 — Usefulness of NESA Microcurrents in the Treatment of Children With Autism Spectrum Disorders · NA · completed
- NCT06134999 — Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation · NA · completed
- NCT06138158 — Improvement of Fear-avoidance Beliefs in Patients With Chronic Low Back Pain · NA · completed
- NCT05800431 — NESA Microcurrents on Quality of Life in Geriatric Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05265494 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Las Palmas de Gran Canaria
- Last refreshed: 18 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05265494.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing